- Home
- IVDA vs APM Comparison
IVDA vs APM Comparison
Compare IVDA & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- APM
- Stock Information
- Founded
- IVDA 2003
- APM 2010
- Country
- IVDA United States
- APM United Kingdom
- Employees
- IVDA N/A
- APM N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- APM Health Care
- Exchange
- IVDA Nasdaq
- APM Nasdaq
- Market Cap
- IVDA 6.7M
- APM 6.1M
- IPO Year
- IVDA N/A
- APM 2018
- Fundamental
- Price
- IVDA $2.42
- APM $1.07
- Analyst Decision
- IVDA
- APM
- Analyst Count
- IVDA 0
- APM 0
- Target Price
- IVDA N/A
- APM N/A
- AVG Volume (30 Days)
- IVDA 112.4K
- APM 81.2K
- Earning Date
- IVDA 05-13-2025
- APM 06-17-2025
- Dividend Yield
- IVDA N/A
- APM N/A
- EPS Growth
- IVDA N/A
- APM N/A
- EPS
- IVDA N/A
- APM N/A
- Revenue
- IVDA $7,148,449.00
- APM N/A
- Revenue This Year
- IVDA $340.48
- APM N/A
- Revenue Next Year
- IVDA N/A
- APM N/A
- P/E Ratio
- IVDA N/A
- APM N/A
- Revenue Growth
- IVDA 54.15
- APM N/A
- 52 Week Low
- IVDA $1.27
- APM $0.46
- 52 Week High
- IVDA $8.05
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- IVDA 54.36
- APM 58.89
- Support Level
- IVDA $1.98
- APM $0.83
- Resistance Level
- IVDA $2.70
- APM $1.35
- Average True Range (ATR)
- IVDA 0.22
- APM 0.12
- MACD
- IVDA 0.06
- APM 0.02
- Stochastic Oscillator
- IVDA 64.45
- APM 46.97
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.